BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fantuzzi L, Tagliamonte M, Gauzzi MC, Lopalco L. Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders. Cell Mol Life Sci 2019;76:4869-86. [PMID: 31377844 DOI: 10.1007/s00018-019-03255-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Riviere-Cazaux C, Cornell J, Shen Y, Zhou M. The role of CCR5 in HIV-associated neurocognitive disorders. Heliyon 2022;8:e09950. [PMID: 35865985 DOI: 10.1016/j.heliyon.2022.e09950] [Reference Citation Analysis]
2 Shen Y, Zhu Z, Wang R, Yan L, Sun S, Lu L, Ren Z, Zhang Q. Chemokine (C-C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children. BMC Nephrol 2022;23:215. [PMID: 35725391 DOI: 10.1186/s12882-022-02839-y] [Reference Citation Analysis]
3 Popović-djordjević J, Quispe C, Giordo R, Kostić A, Katanić Stanković JS, Tsouh Fokou PV, Carbone K, Martorell M, Kumar M, Pintus G, Sharifi-rad J, Docea AO, Calina D. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Sharif-zak M, Abbasi-jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-jabalbarzi M, afsharipur A, Rashidinejad H, Khajepour F, Jafarzadeh A, Arefinia N, Kheyrkhah A, Abolhassani M. CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender. Immunobiology 2022;227:152184. [DOI: 10.1016/j.imbio.2022.152184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Nemska S, Gassmann M, Bang ML, Frossard N, Tavakoli R. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice. J Cardiovasc Pharmacol 2021;78:792-801. [PMID: 34882111 DOI: 10.1097/FJC.0000000000001130] [Reference Citation Analysis]
6 Cherney RJ, Anjanappa P, Selvakumar K, Batt DG, Brown GD, Rose AV, Vuppugalla R, Chen J, Pang J, Xu S, Yarde M, Tebben AJ, Paidi VR, Cvijic ME, Mathur A, Barrish JC, Mandlekar S, Zhao Q, Carter PH. BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate. ACS Med Chem Lett 2021;12:1753-8. [PMID: 34795864 DOI: 10.1021/acsmedchemlett.1c00373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huang Y, Wang X, Zhou D, Zhou W, Dai F, Lin H. Macrophages in heterotopic ossification: from mechanisms to therapy. NPJ Regen Med 2021;6:70. [PMID: 34702860 DOI: 10.1038/s41536-021-00178-4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 He Y, de Araújo Júnior RF, Cruz LJ, Eich C. Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy. Pharmaceutics 2021;13:1670. [PMID: 34683963 DOI: 10.3390/pharmaceutics13101670] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Wang Y, Zhang T, Sun M, Ji X, Xie M, Huang W, Xia L. Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes. Cancers (Basel) 2021;13:5127. [PMID: 34680276 DOI: 10.3390/cancers13205127] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Yao Z, Chen P, Fan L, Chen P, Zhang X, Yu B. CCL2 is a critical mechano-responsive mediator in crosstalk between osteoblasts and bone mesenchymal stromal cells. FASEB J 2021;35:e21851. [PMID: 34547121 DOI: 10.1096/fj.202002808RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Muscate F, Woestemeier A, Gagliani N. Functional heterogeneity of CD4+ T cells in liver inflammation. Semin Immunopathol 2021;43:549-61. [PMID: 34463867 DOI: 10.1007/s00281-021-00881-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 DeNardo DG, Galkin A, Dupont J, Zhou L, Bendell J. GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors. J Immunother Cancer 2021;9:e003005. [PMID: 34452928 DOI: 10.1136/jitc-2021-003005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Karakaya B, van Moorsel CHM, Veltkamp M, Roodenburg-Benschop C, Kazemier KM, van der Helm-van Mil AHM, Huizinga TWJ, Grutters JC, Rijkers GT. A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren's Syndrome and Alters Receptor Expression as well as Functional Response. Cells 2021;10:1967. [PMID: 34440736 DOI: 10.3390/cells10081967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Rossi AJ, Khan TM, Saif A, Marron TU, Hernandez JM. Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody. Ann Surg Oncol 2021. [PMID: 34117573 DOI: 10.1245/s10434-021-10269-7] [Reference Citation Analysis]
15 Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol 2021;:107598. [PMID: 34233864 DOI: 10.1016/j.intimp.2021.107598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu F, Wu H. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets. J Inflamm Res 2021;14:267-85. [PMID: 33574689 DOI: 10.2147/JIR.S278395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Rubio T, Felipo V, Tarazona S, Pastorelli R, Escudero-García D, Tosca J, Urios A, Conesa A, Montoliu C. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients. Sci Rep 2021;11:1907. [PMID: 33479266 DOI: 10.1038/s41598-020-80941-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Jin H, Xia J, Liu Z, Wang XS, Zhang L. A unique ligand-steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure-based virtual screening. Chem Biol Drug Des 2021;97:944-61. [PMID: 33386704 DOI: 10.1111/cbdd.13820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Necula D, Riviere-Cazaux C, Shen Y, Zhou M. Insight into the roles of CCR5 in learning and memory in normal and disordered states. Brain Behav Immun 2021;92:1-9. [PMID: 33276089 DOI: 10.1016/j.bbi.2020.11.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wagner S, de Moura Gatti F, Silva DG, Ortiz Zacarias NV, Zweemer AJM, Hermann S, De Maria M, Koch M, Weiss C, Schepmann D, Heitman LH, Tschammer N, Kopka K, Junker A. Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors. ChemMedChem 2021;16:640-5. [PMID: 33205603 DOI: 10.1002/cmdc.202000728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Matsuzaka Y, Tanihata J, Ooshima Y, Yamada D, Sekiguchi M, Miyatake S, Aoki Y, Terumitsu M, Yashiro R, Komaki H, Ishiyama A, Oya Y, Inoue YU, Inoue T, Takeda S, Hashido K. The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice. BMC Med 2020;18:343. [PMID: 33208172 DOI: 10.1186/s12916-020-01805-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen Y, Jin H, Song Y, Huang T, Cao J, Tang Q, Zou Z. Targeting tumor-associated macrophages: A potential treatment for solid tumors. J Cell Physiol 2021;236:3445-65. [PMID: 33200401 DOI: 10.1002/jcp.30139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
23 Yeregui E, Viladés C, Domingo P, Ceausu A, Pacheco YM, Veloso S, Inciarte A, Vidal-González J, Peraire M, Perpiñán C, Falcó V, Masip J, Alba V, Vargas M, Martí A, Reverté L, Mallolas J, Vidal F, Peraire J, Rull A. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients. EBioMedicine 2020;62:103077. [PMID: 33166788 DOI: 10.1016/j.ebiom.2020.103077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sanchez-Schmitz G, Morrocchi E, Cooney M, Soni D, Khatun R, Palma P, Dowling DJ, Levy O. Neonatal monocytes demonstrate impaired homeostatic extravasation into a microphysiological human vascular model. Sci Rep 2020;10:17836. [PMID: 33082466 DOI: 10.1038/s41598-020-74639-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Li M, Chen L, Gao Y, Li M, Wang X, Qiang L, Wang X. Recent advances targeting C-C chemokine receptor type 2 for liver diseases in monocyte/macrophage. Liver Int 2020;40:2928-36. [PMID: 33025657 DOI: 10.1111/liv.14687] [Reference Citation Analysis]
26 Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA. Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. J Inflamm Res 2020;13:619-33. [PMID: 33061527 DOI: 10.2147/JIR.S270872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
27 Wang X, Wang D, Wang X, Wang X, Sha JC, Gao Q. Mechanisms underlying the production of chemokine CXCL11 in the reaction of renal tubular epithelial cells with CD4+ and CD8+ T cells. Transpl Immunol 2021;65:101337. [PMID: 32971208 DOI: 10.1016/j.trim.2020.101337] [Reference Citation Analysis]
28 Zhou K, Cheng T, Zhan J, Peng X, Zhang Y, Wen J, Chen X, Ying M. Targeting tumor-associated macrophages in the tumor microenvironment. Oncol Lett 2020;20:234. [PMID: 32968456 DOI: 10.3892/ol.2020.12097] [Cited by in Crossref: 9] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
29 Koo SY, Park EJ, Lee CW. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Exp Mol Med 2020;52:1209-19. [PMID: 32770081 DOI: 10.1038/s12276-020-0480-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
30 Doulberis M, Papadimitriou K, Papaefthymiou A, Kountouras J, Polyzos SA. The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis. Exploration of Medicine 2020;1:170-83. [DOI: 10.37349/emed.2020.00012] [Reference Citation Analysis]
31 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Olmo EMD, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Smith N, Hall JM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Res Sq 2020:rs. [PMID: 32702719 DOI: 10.21203/rs.3.rs-30934/v2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
32 Chang Y, Li H. Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success? J Clin Transl Hepatol 2020;8:222-9. [PMID: 32832403 DOI: 10.14218/JCTH.2020.00026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
33 Ellwanger JH, Kulmann-Leal B, Kaminski VL, Rodrigues AG, Bragatte MAS, Chies JAB. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases. Virus Res 2020;286:198040. [PMID: 32479976 DOI: 10.1016/j.virusres.2020.198040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
34 Ye W, Liu X, Bai Y, Tang N, Wu G, Wang X, Cheng J, Liu L. Sepsis Activates the TLR4/MyD88 Pathway in Schwann Cells to Promote Infiltration of Macrophages, Thereby Impeding Neuromuscular Function. Shock 2021;55:90-9. [PMID: 32433207 DOI: 10.1097/SHK.0000000000001557] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kwiatkowski K, Ciapała K, Rojewska E, Makuch W, Mika J. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses. Int Immunopharmacol 2020;84:106540. [PMID: 32402949 DOI: 10.1016/j.intimp.2020.106540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Souza-Souza KFC, Gonçalves-de-Albuquerque CF, Cirne-Santos C, Paixão ICNP, Burth P. Alphavirus Replication: The Role of Cardiac Glycosides and Ion Concentration in Host Cells. Biomed Res Int 2020;2020:2813253. [PMID: 32461975 DOI: 10.1155/2020/2813253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Cui LY, Chu SF, Chen NH. The role of chemokines and chemokine receptors in multiple sclerosis. Int Immunopharmacol 2020;83:106314. [PMID: 32197226 DOI: 10.1016/j.intimp.2020.106314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
38 Liu Q, Song J, Pan Y, Shi D, Yang C, Wang S, Xiong B. Wnt5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression. Int J Biol Sci 2020;16:1023-34. [PMID: 32140070 DOI: 10.7150/ijbs.40535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
39 Kopecky BJ, Frye C, Terada Y, Balsara KR, Kreisel D, Lavine KJ. Role of donor macrophages after heart and lung transplantation. Am J Transplant 2020;20:1225-35. [PMID: 31850651 DOI: 10.1111/ajt.15751] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
40 Siracusano G, Tagliamonte M, Buonaguro L, Lopalco L. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines (Basel) 2020;8:E41. [PMID: 31991677 DOI: 10.3390/vaccines8010041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Miao M, De Clercq E, Li G. Clinical significance of chemokine receptor antagonists. Expert Opin Drug Metab Toxicol 2020;16:11-30. [PMID: 31903790 DOI: 10.1080/17425255.2020.1711884] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
42 Donyavi T, Bokharaei-Salim F, Nahand JS, Garshasbi S, Esghaei M, Sadeghi M, Jamshidi S, Khanaliha K. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population. J Med Virol 2020;92:1158-64. [PMID: 31854469 DOI: 10.1002/jmv.25658] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Ortiz Zacarías NV, van Veldhoven JPD, den Hollander LS, Dogan B, Openy J, Hsiao YY, Lenselink EB, Heitman LH, IJzerman AP. Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5. J Med Chem 2019;62:11035-53. [PMID: 31742400 DOI: 10.1021/acs.jmedchem.9b00742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]